title: The current landscape of multiple myeloma treatment.
authors.affiliation: Seràgnoli Institute of Hematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Cavo
authors.forename: Michel
authors.initials: M
authors.lastname: Attal
authors.forename: Morie A
authors.initials: MA
authors.lastname: Gertz
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
authors.forename: Heinz
authors.initials: H
authors.lastname: Ludwig
authors.forename: Gareth J
authors.initials: GJ
authors.lastname: Morgan
authors.forename: Kenneth C
authors.initials: KC
authors.lastname: Anderson
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D017024:Chemotherapy, Adjuvant / Q000379:methods / Q000639:trends; D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D033581:Stem Cell Transplantation / Q000639:trends; D016019:Survival Analysis; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D014182:Transplantation, Autologous
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide